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Abstract
Aims/hypothesis We aimed to identify critical periods and
specific longitudinal growth patterns from fetal life onwards
associated with childhood insulin and C-peptide levels.
Methods In a prospective population-based cohort study of
4328 children, we repeatedly measured (femur) length and
(estimated fetal) weight from the second trimester of fetal life
until 6 years of age. BMI was calculated from 6 months on-
wards. Insulin and C-peptide levels were measured at 6 years
of age.
Results Preterm birth and small or large size for gestational
age at birth were not associated with childhood insulin levels.
Conditional growth modelling showed that, independent of
growth in other time intervals, weight growth in each time
interval from birth onwards, length growth from 6 months
onwards and BMI growth from 12 months onwards were pos-
itively associated with childhood insulin levels. The strongest
associations were present for weight and BMI growth between
48 and 72 months of age. Repeated measurement analyses
showed that, compared with children in the lowest quartile
of childhood insulin, those in the highest quartile had a higher
length from birth onwards and a higher weight and BMI from
24 months onwards. These differences increased with age. No
associations were observed for fetal growth characteristics.
Similar results were observed for C-peptide levels.
Conclusions/interpretation Our results suggest that rapid
length, weight and BMI growth from birth onwards, but
not during fetal life, is associated with higher insulin levels
in childhood.
Keywords Bodymass index . Childhood . C-peptide . Fetal
life . Growth . Insulin . Length . Prospective cohort
Abbreviations
AC Abdominal circumference
AGA Appropriate for gestational age
EFW Estimated fetal weight
FL Femur length
HC Head circumference
LGA Large for gestational age
SDS Standard deviation score
SGA Small for gestational age
Introduction
A large body of evidence suggests that adverse exposures in
early life influence the risk of type 2 diabetes in later life [1].
Multiple previous studies have shown that adults born with
either a low or high birthweight are at increased risk of type 2
diabetes [2, 3]. Birthweight is often used as a proxy for fetal
growth. However, since birthweight is the result of different
fetal growth patterns and is the starting point of infant growth,
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birthweight is not a causal factor per se in the development of
type 2 diabetes. Studies assessing the associations of directly
measured fetal growth characteristics with measures of glu-
cose or insulin metabolism in later life are scarce and focused
on measures of growth during specific trimesters only [4, 5].
As the development of the endocrine pancreas starts as early
as the first trimester [6], fetal life might be a critical period for
glucose and insulin metabolism, and the development of type
2 diabetes in later life.
More research has been performed on childhood growth
patterns related to the risk of type 2 diabetes in later life
[7–11]. These studies showed that participants who developed
type 2 diabetes in adulthood were small at birth and thin in
infancy. During childhood, they gained weight rapidly, lead-
ing to an average or above average BMI at the age of 11 years.
Furthermore, weight gain during the first 6 months of life was
more strongly related to the risk of insulin resistance in adult-
hood compared with weight gain later in infancy [9].
Thus far, there have been no studies to explore the associ-
ations of directly measured fetal growth characteristics or the
combined associations of repeatedly measured fetal and child-
hood growth characteristics with insulin metabolism in later
life. It is also not clear which time period of growth is most
important for later insulin metabolism. Therefore, we aimed to
identify critical periods and specific growth patterns from fetal
life onwards that are important for the development of subop-
timal insulin metabolism in childhood. Among 4328 partici-
pants of a population-based prospective cohort study from
early pregnancy onwards, we assessed the associations of di-
rectly measured fetal and childhood growth characteristics
with insulin and C-peptide levels at 6 years of age.
Methods
Study design This study was embedded in the Generation R
Study, a population-based prospective cohort study from early
pregnancy onwards performed in Rotterdam, the Netherlands
[12, 13]. The study was approved by the Medical Ethical
Committee of the Erasmus Medical Center, University
Medical Center, Rotterdam (MEC 198.782/2001/31).
Written informed consent was obtained from all mothers.
The response rate at birth was 61%. In total, 9901 children
were enrolled in the study. As growth represents a change in
size between two time points, we included children who had
measurements of fetal or childhood growth characteristics
available at, at least, two different time points (n=9639). Of
these children, 9395 were singleton and live-born, 6522 par-
ticipated in the follow-up measurements at 6 years of age and
4328 had information on insulin or C-peptide levels available
(ESM Fig. 1). Missing data on insulin and C-peptide levels
were mainly due to lack of consent for venous punctures or
non-successful venous punctures [13].
Fetal and childhood growth characteristics We performed
fetal ultrasound examinations in each trimester of pregnancy.
As described previously, gestational age was established using
data from the first fetal ultrasound examination [14]. Second
and third trimester fetal head circumference (HC), abdominal
circumference (AC) and femur length (FL) were measured to
the nearest millimetre using standardised ultrasound proce-
dures. We calculated estimated fetal weight (EFW) using the
formula of Hadlock et al [15]: log10 EFW=1.5662−0.0108
(HC)+0.0468 (AC)+0.171 (FL)+0.00034 (HC)2−0.003685
(AC×FL). Information on child’s sex, gestational age, weight
and length at birth was obtained frommedical records. Preterm
birth was defined as a gestational age at birth <37 weeks. Low
birthweight was defined as a birthweight ≤2500 g and high
birthweight was defined as a birthweight ≥4000 g. Small and
large size for gestational age at birth were defined as the lowest
and the highest ten percentiles of gestational age and sex-
adjusted birthweight in the complete cohort.
Well-trained staff in community health centres obtained
childhood growth characteristics (length and weight) accord-
ing to standard schedules and procedures at 6, 12, 24, 36 and
48 months of age. Growth characteristics at 72 months were
obtained in a dedicated research centre following standardised
protocols. We calculated BMI (kg/m2) at each time point from
6 months onwards. Standard deviation scores (SDS) were
constructed for all growth characteristics using reference
charts from the complete cohort for fetal measurements [14],
northern European growth charts for birth measurements [16]
and Dutch growth reference charts for childhood growth char-
acteristics (Growth Analyzer 3.0; Dutch Growth Research
Foundation, Rotterdam, the Netherlands) [17].
Childhood insulin and C-peptide levels At 6 years of age,
30 min fasting venous blood samples were obtained in a well-
equipped and dedicated research centre in the Erasmus
Medical Center Sophia Children’s hospital, Rotterdam, the
Netherlands [12]. All blood samples were stored for a maxi-
mum of 4 h at 4°C. Blood samples were transported twice
daily to the laboratory facility of the regional laboratory in
Rotterdam, the Netherlands (STAR-MDC), where they were
processed and stored within 4 h of venous puncture [13].
Insulin (pmol/l) and C-peptide levels (nmol/l) were obtained
enzymatically using a Cobas 8000 Analyzer (Roche, Almere,
the Netherlands). Quality control samples demonstrated intra-
and inter-assay coefficients of variation of 1.39% and 2.40%,
respectively. As C-peptide is secreted in equal amounts but
has a longer half-life compared with insulin, we included C-
peptide levels as an additional, more stable, outcome measure.
CovariatesWe assessed maternal age, pre-pregnancy weight,
parity, ethnicity, educational level and folic acid use by ques-
tionnaire at enrolment in the study. Maternal height was mea-
sured and pre-pregnancy BMI was calculated. Smoking
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during pregnancy was repeatedly assessed by questionnaire
throughout pregnancy. We obtained information on gestation-
al hypertensive disorders (gestational hypertension and pre-
eclampsia) and gestational diabetes from medical records
[18]. Information on breastfeeding and the timing of introduc-
tion to solid foods was assessed by questionnaire during in-
fancy, and the average time watching television was assessed
by questionnaire at 6 years of age.
Statistical analysis First, we assessed the associations of ges-
tational age at birth (preterm, term), birthweight (low, normal,
high) and size for gestational age at birth (small, appropriate,
large) with childhood insulin and C-peptide levels using mul-
tiple linear regression models. Second, to identify specific
critical periods of growth associated with childhood insulin
and C-peptide levels, we used conditional growth modelling
[19–21]. We constructed length, weight and BMI growth var-
iables, which are statistically independent from each other,
using the standardised residuals obtained from the linear re-
gression models of length, weight and BMI regressed on all
prior corresponding growth measurements (ESMMethods 1).
This enables inclusion of the growth measurements at all time
points simultaneously in one model, and thus to estimate the
independent andmutually adjusted influence of growth during
each time interval on childhood insulin and C-peptide levels
[19–21]. Third, in order to examine the associations of longi-
tudinal fetal and childhood growth patterns with childhood
insulin and C-peptide levels, we used unbalanced repeated
measurement models. These models allow for incomplete out-
come data and take the correlation between repeated measure-
ments of the same participant into account by modelling the
correlated errors of these measurements. For these analyses,
we constructed quartiles of childhood insulin and C-peptide
levels. These categories were included in the models as inter-
cept and as interaction terms with (gestational) age to study
the (gestational) age-independent effects (difference constant
over time) as well as (gestational) age-dependent effects (dif-
ference non-constant over time). The actual models are de-
scribed in more detail in ESM Methods 2.
All models were first adjusted for the child’s sex and age at
insulin and C-peptide measurement only (basic models), and
were subsequently adjusted for maternal and childhood
sociodemographic and lifestyle related characteristics (adjust-
ed models). The models for birth outcomes were also adjusted
for childhood BMI at insulin and C-peptide measurement. We
included covariates in the models based on their associations
with the outcomes of interest in previous studies, a significant
association with the determinants and outcomes, or a change
in effect estimates of >10%. The associations between all
growth characteristics and childhood insulin and C-peptide
levels were linear. We tested for interactions between
birthweight and BMI at the age of insulin and C-peptide mea-
surement, birthweight and child’s sex, and BMI at the age of
insulin and C-peptide measurement and child’s sex in the
models described above, but no significant interactions were
present (p values for interaction >0.05). In order to obtain
normal distributions, we square root transformed insulin and
C-peptide levels. SDS were constructed for insulin and C-
peptide levels, defined as (observed value minus mean value
of the reference population)/SD, to enable comparison of ef-
fect estimates.We usedmultiple imputation for missing values
of covariates (<32%) and for the growth characteristics
(<46%) for conditional growth modelling only by generating
five independent datasets using the Markov Chain Monte
Carlo (MCMC) method. Pooled effect estimates were present-
ed. We performed a sensitivity analysis in children with
growth characteristics available at all time points, which did
not materially change the main findings (results not shown).
The repeated measurement analyses were performed using the
Statistical Analysis System version 9.3 (SAS Institute, Cary,
NC, USA). All other analyses were performed using the
Statistical Package of Social Sciences version 21.0 for
Windows (IBM, Armonk, NY, USA).
Results
Study population Table 1 shows the characteristics of the
study population. At 6 years of age, the median insulin and
C-peptide levels were 112 pmol/l (95% range 17, 395) and
0.95 nmol/l (95% range 0.30, 2.14), respectively. ESMTable 1
shows the growth characteristics at each time point. Non-
response analysis showed that the mothers of children not in-
cluded in the analyses were more likely to have a lower level of
education and to smoke more often compared with the mothers
of children included in the analyses (ESM Table 2).
Furthermore, children not included in the analysis were less
often from European descent. No or minor differences in child-
hood growth characteristics were observed between the groups.
Critical periods of early growthWe did not observe associ-
ations of gestational age at birth, birthweight or size for ges-
tational age at birth with childhood insulin levels in the basic
or the adjusted models (Table 2). After additional adjustment
for childhood current BMI, tendencies to inverse associations
of birthweight and size for gestational age at birth with child-
hood insulin levels were present. The results were similar for
childhood C-peptide levels (ESM Table 3).
Figure 1 shows the associations of growth during specific
time intervals, conditional on prior growth measurements,
with childhood insulin levels (adjusted models). No associa-
tions were observed for growth during specific periods in fetal
life. Independent of growth in other time intervals, weight
growth in each time interval from birth onwards, length
growth in each time interval from 6 months onwards and
BMI growth in each time interval from 12 months onwards
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were positively associated with childhood insulin levels
(p<0.05). The strongest associations were present for weight
and BMI growth between 48 and 72 months. The results ob-
tained from the basic model were consistent (ESM Fig. 2).
Similar results were also observed for childhood C-peptide
levels (ESM Figs 2, 3).
Fetal and childhood growth patterns Figure 2a–c shows the
growth patterns from fetal life onwards for children in the
higher childhood insulin quartiles compared with children in
the lowest childhood insulin quartile. The overall growth pat-
terns for fetal weight and length did not differ between the
insulin quartiles (p values for trend >0.05). During childhood,
length, weight and BMI gain were faster for children in the
higher insulin quartiles (p values for trend <0.05). The largest
differences were observed for children in the highest insulin
quartile. Compared with children in the lowest insulin quar-
tile, children in the highest insulin quartile were taller from
birth onwards. Furthermore, they had a higher weight and
BMI from 24 months onwards. These differences increased
with age. ESMFig. 4a–c shows the growth patterns associated
with childhood C-peptide levels, which were similar to those
for insulin levels. The regression coefficients for (gestational)
age-independent (intercept) and (gestational) age-dependent
effects (interaction between the insulin or C-peptide quartiles
and (gestational) age) are given in ESM Tables 4 and 5.
Discussion
In this prospective population-based cohort study, rapid
length, weight and BMI growth from birth onwards was
associated with higher childhood insulin levels. Although
the strongest associations were present for weight and BMI
growth between 48 and 72 months, we also observed inde-
pendent associations of postnatal weight and BMI growth
with childhood insulin levels at earlier time intervals. No
associations were observed for fetal growth characteristics.
Table 1 Characteristics of the
study population Total group N= 4328
Maternal characteristics
Age at intake (years), mean (SD) 30.7 (5.1)
Height (cm), mean (SD) 167.7 (7.5)
Pre-pregnancy weight (kg), median (95% range) 64.0 (49.0, 98.0)
Pre-pregnancy BMI (kg/m2), median (95% range) 22.7 (18.1, 34.5)
Highest education completed, n (%)
Primary 343 (8.7)
Secondary 1692 (43.1)
Higher 1887 (48.1)
Parity, nulliparous (%) 2299 (55.1)
Ethnicity, European (%) 2605 (61.9)
Folic acid use, yes (%) 2239 (75.3)
Smoking during pregnancy, yes (%) 601 (16.0)
Gestational diabetes, yes (%) 42 (1.0)
Pre-eclampsia, yes (%) 65 (1.8)
Gestational hypertension, yes (%) 155 (4.2)
Child characteristics
Sex, male (%) 2235 (51.6)
Gestational age at birth (weeks), median (95% range) 40.1 (35.8, 42.3)
Birthweight (g), median (95% range) 3450 (2261, 4474)
Ever breastfed, yes (%) 3150 (92.5)
Introduction of solid foods before 6 months, yes (%) 2328 (89.9)
Ethnicity, European (%) 2730 (64.8)
Television watching >2 h/day, n (%) 672 (19.9)
Age at 6-year follow-up examination (years), median (95% range) 6.0 (5.7, 8.0)
BMI (kg/m2), median (95% range) 15.9 (13.7, 21.2)
Insulin at 6 years (pmol/l), median (95% range) 112 (17, 395)
C-peptide at 6 years (nmol/l), median (95% range) 0.95 (0.30, 2.14)
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Strengths and limitations In this prospective population-
based study, we had repeatedly measured growth characteris-
tics available from fetal life onwards, enabling us to study the
combined associations of fetal and childhood growth
characteristics with childhood insulin and C-peptide levels.
Of all eligible children at baseline, 54% were not included in
the analyses. We consider it unlikely that this led to selection
bias, since no or only minor differences were observed
Table 2 Associations of birth
outcomes with childhood insulin
levels (n = 4286)
Birth outcome n Insulin (SDS [95% CI])
Basic model Adjusted model BMI-adjusted model
Gestational age at birth
Preterm (<37 weeks) 213 0 (−0.14, 0.14) −0.03 (−0.18, 0.13) −0.07 (−0.22, 0.08)
Term (≥37 weeks) 4051 Reference Reference Reference
p value for trend 4264 0.957 0.743 0.358
Birthweight
Low (≤2500 g) 187 −0.01 (−0.16, 0.14) 0.06 (−0.12, 0.23) 0.12 (−0.06, 0.29)
Normal (2500–3999 g) 3474 Reference Reference Reference
High (≥4000 g) 625 −0.03 (−0.12, 0.05) −0.07 (−0.16, 0.02) −0.13 (−0.22, −0.04)*
p value for trend 4286 0.529 0.098 0.002
Size for gestational age
SGA (≤10th percentile) 363 −0.01 (−0.11, 0.10) 0.01 (−0.10, 0.12) 0.08 (−0.03, 0.19)
AGA (10–90th percentile) 3447 Reference Reference Reference
LGA (≥90th percentile) 444 −0.04 (−0.14, 0.06) −0.06 (−0.16, 0.04) −0.12 (−0.22, −0.02)*
p value for trend 4254 0.635 0.276 0.005
Values are regression coefficients that reflect the differences in insulin SDS between the groups of the different
birth outcomes
The basic models are adjusted for child’s sex and age at insulin and C-peptide measurement. The adjusted models
are further adjusted for maternal pre-pregnancy BMI, maternal age, parity, smoking during pregnancy, folic acid
use, maternal education level, gestational diabetes, gestational hypertensive disorders, ethnicity of the child,
gestational age at birth (for birthweight) and birthweight (for gestational age at birth). The BMI-adjusted models
are the adjusted models with additional adjustment for childhood BMI at insulin and C-peptide measurement
p values for trend were obtained by entering the categorical variables to the models as continuous variables
*p< 0.05
AGA, appropriate for gestational age; LGA, large for gestational age; SGA, small for gestational age
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Fig. 1 Associations of fetal and childhood growth, conditional on prior
measurements, with childhood insulin levels (n=4293). Values are regres-
sion coefficients representing differences in childhood insulin SDS per
standardised residual change in growth characteristic in each time interval.
The standardised residuals were obtained from models in which the growth
measures of interest were regressed on the prior corresponding growth mea-
sures. For models presented for length and weight, the initial measure of size
(starting point) was at 20 weeks of gestation (FL and EFW), and for BMI at
6 months of age. The models are adjusted for child’s sex, age at insulin and
C-peptide measurement, maternal pre-pregnancy BMI, maternal age, parity,
smoking during pregnancy, folic acid use, maternal education level, gesta-
tional diabetes, gestational hypertensive disorders, ethnicity of the child,
gestational age at birth, breastfeeding, timing of introduction of solid foods
and time watching television. Circles, length; squares, weight; triangles,
BMI; wks, weeks; mo, months
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between the growth characteristics of children included in the
analyses and children not included in the analyses.
The fasting time before venous puncture was limited. Due
to the design of the study and the young age of the children,
wewere not able to collect blood samples after a longer fasting
period [12]. This may have led to some non-differential mis-
classification and underestimation of the observed effect esti-
mates. This may especially affect childhood insulin levels,
which are less stable and have a shorter half-life compared
with C-peptide levels. In addition, information on glucose
levels was not available and therefore we were unable to esti-
mate insulin sensitivity. However, as blood glucose levels are
less variable than insulin levels, especially in children, and
most of the variability in insulin sensitivity is due to insulin
levels, we consider insulin levels to be a useful proxy of insu-
lin sensitivity [22, 23]. Further studies are needed to assess the
associations of fetal and childhood growth with detailed and
fasting measures of offspring glucose and insulin metabolism.
As insulin is known to stimulate growth and fat deposition,
it might be possible that the associations observed were due to
reverse causation [24]. However, as information on insulin
and C-peptide levels was only available at 6 years of age,
we were not able to assess this possibility in our study.
The prospective design of the study from early preg-
nancy onwards enabled us to take into account numerous
potential maternal and childhood confounders. However,
some residual confounding might be present in the re-
ported effect estimates as, for example, detailed dietary
information was not available.
Interpretation of main findings An accumulating body of
evidence suggests that adverse exposures in early life in-
fluence the risk of type 2 diabetes in later life. Multiple
studies have reported associations of birthweight with
measures of glucose and insulin metabolism in children
as well as adults, some of them depending on adjustment
for current body size [2–4, 9, 25]. We did not observe
associations of gestational age at birth, birthweight or size
for gestational age at birth with childhood insulin or C-
peptide levels. After adjustment for childhood current
BMI, tendencies to inverse associations for birthweight
and size for gestational age at birth were present.
However, it has been argued that adjusting early size for
later size reflects the change in size between these two
time points [26]. This suggests that the change between
the growth characteristics at birth and in childhood is
related to childhood insulin and C-peptide levels rather
than birthweight per se.
Thus far, critical periods from fetal life onwards associ-
ated with the development of type 2 diabetes remain un-
clear, as previous studies mainly used birthweight as a
proxy of fetal growth. Among 123 Danish adolescents, fetal
growth velocity during the third trimester was not associat-
ed with any measure of insulin or glucose metabolism [4].
In our own study cohort, first trimester crown to rump
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Fig. 2 Fetal and childhood growth patterns according to insulin quartile
(n= 4293). Results are based on repeated linear regression models and
reflect the differences in SDS of (a) length (based on 39,022 measure-
ments), (b) weight (based on 42,630 measurements) and (c) BMI (based
on 23,277 measurements) growth in children with insulin levels in the
second, third and fourth quartiles (insulin levels 62.7–112.4, 112.5–186.9
and 187.0–569.7 pmol/l, respectively), compared with those with insulin
levels in the first quartile (2.7–62.6 pmol/l). The reference value is an SDS
of 0. The models were adjusted for child’s sex, maternal pre-pregnancy
BMI, maternal age, parity, smoking during pregnancy, folic acid use,
maternal education level, gestational diabetes, gestational hypertensive
disorders, ethnicity of the child, gestational age at birth, breastfeeding,
timing of introduction of solid foods and time watching television.
Circles/dotted line, second insulin quartile; triangles/dashed line, third
insulin quartile; squares/solid line, fourth insulin quartile
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length was not associated with childhood insulin levels [5].
In childhood, results from the Helsinki birth cohort suggest
that growth during the first 6 months is critical for the de-
velopment of insulin resistance in adulthood [9]. In a study
of 1124 children from England and Wales, both a lower
birthweight and a higher childhood ponderal index were
associated with higher fasting and postload insulin levels
at 10–11 years, with stronger effect estimates for the child-
hood ponderal index [25]. Furthermore, a recent study
among 3301 European children with a mean age of 8.5 years
showed that rapid BMI growth between 9 months and
6 years was related to a higher risk of insulin resistance
[27]. In our current study, growth during fetal life was not
associated with childhood insulin or C-peptide levels, inde-
pendent of growth in other time intervals. Weight growth
from birth onwards, length growth from 6 months onwards
and BMI growth from 12 months onwards were indepen-
dently and positively associated with childhood insulin and
C-peptide levels. The strongest associations were present
for weight and BMI growth between 48 and 72 months.
These results suggest that growth during childhood, espe-
cially in weight and BMI, is important for the development
of a suboptimal insulin metabolism in childhood, irrespec-
tive of growth during fetal life.
Observations from previous studies suggest that a
growth pattern characterised by a low birthweight, follow-
ed by a rapid childhood weight gain, is associated with
increased risk of insulin resistance or type 2 diabetes in later
life [9–11]. We observed no associations of fetal growth
patterns with childhood insulin and C-peptide levels.
During childhood, children with higher insulin and
C-peptide levels had a growth pattern characterised by a
high weight and BMI, which increased throughout child-
hood. This suggests that children with relatively high child-
hood insulin or C-peptide levels grow faster during child-
hood but might not have grown differently during fetal life.
Thus, our results suggest that rapid growth through-
out childhood is important for the development of sub-
optimal insulin metabolism in childhood, rather than fe-
tal growth. It has been proposed that adverse exposures
during fetal life lead to reduced muscle mass, reduced
muscle sensitivity to insulin, and changes in the struc-
ture and function of the beta cells, which may subse-
quently lead to insulin resistance and beta cell dysfunc-
tion in later life [28–30]. Since only childhood growth
characteristics were related to childhood insulin and C-
peptide levels in our study, the mechanisms underlying
these associations may involve differences in the body
composition of the child, for example an increased body
fat mass resulting from rapid postnatal growth or genet-
ic influences, rather than developmental adaptations dur-
ing fetal life [21, 31–33]. However, it is possible that
associations of fetal growth with insulin or glucose
metabolism become apparent later in life. Furthermore,
the widely described associations of low birthweight
with increased risk of type 2 diabetes may be explained
by beta cell dysfunction, which we were unable to as-
sess in this study [34]. If our findings are confirmed by
other studies with directly measured fetal growth data,
detailed childhood growth data and more detailed mea-
sures of childhood glucose and insulin metabolism, in-
cluding measures of beta cell function, our results un-
derline the importance of strategies aimed at preventing
rapid weight gain throughout childhood to improve in-
sulin metabolism in later life.
Conclusions
Our results suggest that rapid length, weight and BMI gain
from birth onwards, but not growth during fetal life, is asso-
ciated with the development of suboptimal insulin metabolism
in childhood. Further research is needed to replicate our find-
ings and to explore the underlying mechanisms.
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